| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 66 |
| 1 | MYCOPHENOLATE MOFETIL | 63 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 59 |
| 3 | TACROLIMUS OINTMENT 0.1% | 59 |
| 4 | PREDNISONE | 45 |
| 5 | RITUXIMAB | 32 |
| 6 | CYCLOPHOSPHAMIDE | 30 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 30 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 30 |
| 9 | METHYLPREDNISOLONE | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FECAL MICROBIOTA SPORES, LIVE-BRPK | 10 | 0.0079 |
| 1 | TECLISTAMAB-CQYV | 3 | 0.0013 |
| 2 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 10 | 0.0012 |
| 3 | BREXUCABTAGENE AUTOLEUCEL | 2 | 0.0009 |
| 4 | THIOTEPA | 9 | 0.0009 |
| 5 | CHLORAMBUCIL | 3 | 0.0008 |
| 6 | MYCOPHENILIC ACID | 13 | 0.0006 |
| 7 | MYCOPHENOLIC ACID | 19 | 0.0006 |
| 8 | BUSULFAN | 9 | 0.0006 |
| 9 | EVEROLIMUS TABLETS | 9 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 107 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 3 | Alkylating Drug [EPC] | 33 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 30 |
| 5 | Kinase Inhibitor [EPC] | 30 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 7 | Platinum-based Drug [EPC] | 17 |
| 8 | Loop Diuretic [EPC] | 16 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 13 | 0.0006 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 2 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 3 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 6 | 0.0004 |
| 7 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 8 | Antimalarial [EPC] | 3 | 0.0003 |
| 9 | Antiprotozoal [EPC] | 3 | 0.0003 |